Enhancing vaccine immunogenicity through heterologous prime-boost regimen with multiple nasal boosting with liposomal TLR7 ligand. Hayashi T, Yao S, Sato-Kaneko F, Cozza R, et al. Vaccine 2025;65:127778.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hayashi T, Yao S, Sato-Kaneko F, Cozza R, et al. Enhancing vaccine immunogenicity through heterologous prime-boost regimen with multiple nasal boosting with liposomal TLR7 ligand. Vaccine 2025;65:127778.
PMID: 41067087